左心室辅助装置桥接心脏移植的最佳时机:时机是关键吗?
本研究基于2009至2014年2639例医保心脏移植患者,其中1186例(45%)以左心室辅助装置(LVAD)桥接移植(BTT)。按BTT时长分层发现,BTT≤31天者30天和1年生存率显著低于31-365天、>365天及未桥接者;LVAD连续变量分析显示<34天死亡风险显著增加,而>31天各时长间无生存差异。
要点
- LVAD桥接移植≤31天者移植后生存显著劣于更长桥接时长者。
- BTT>31天后不同桥接时长之间未见生存差异。
- 连续变量分析提示LVAD桥接<34天死亡风险显著增加。
核心结论
- 以LVAD桥接心脏移植在第一个月内(≤31天)行移植者死亡风险显著增加,而桥接超过31天后不同时长间无生存差异。
研究设计与样本
- 回顾性队列研究,纳入2009至2014年2639例接受初次心脏移植的付费服务医保患者,其中1186例(45%)以LVAD桥接移植。
- LVAD桥接患者按BTT时长分为≤31天(n=28,2.4%)、31-365天(n=748,63.1%)和>365天(n=409,34.5%),另有1453例(55%)未桥接直接移植。
- LVAD时长以二分类和连续变量分析,主要终点为校正后总生存。
主要发现
- 30天生存率:BTT≤31天为81.5%,31-365天为94%,>365天为95%,未桥接为94%。
- LVAD时长作为连续变量分析时,BTT<34天者死亡风险显著增加。
- BTT超过31天的患者之间未见生存差异。
临床怎么用
- LVAD桥接心脏移植应避免在桥接第一个月内(尤其<34天)过早行移植,以降低死亡风险。
- 桥接超过31天后,移植时机选择对生存影响不大,可依据其他临床因素决定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Due to the scarcity of donor hearts to meet recipient demands, more than 40% of heart transplants are performed in patients bridged to transplant (BTT) with a left ventricular assist device (LVAD). The objective of this study was to determine the effect of BTT duration with an LVAD on posttransplant outcomes. METHODS: From 2009 to 2014, we identified 2639 fee-for-service Medicare patients who underwent a primary heart transplants with 1186 (45%) patients BTT with an LVAD. The LVAD patients were stratified as BTT ≤31 days (n = 28 [2.4%]), BTT 31-365 days (n = 748 [63.1%]), and BTT >365 days (n = 409 [34.5%]). Patients went directly to heart transplantation and were not bridged in 1453 cases (55%). LVAD duration was analyzed dichotomously and as a continuous variable with adjusted overall survival as the primary end point. RESULTS: All-cause mortality was significantly worse in patients who were BTT <31 days. Survival at 30 days was 81.5% for BTT <31 days, 94% for BTT 31 to 365 days, 95% for BTT >365 days, and 94% for no BTT. At 1 year, survival was 74% for BTT <31 days, 85% for BTT 31 to 365 days, 88% for BTT >365 days, and 89% for no BTT (P = .018). When LVAD duration was analyzed as a continuous variable, patients BTT with an LVAD <34 days had significantly increased mortality. CONCLUSIONS: Patients who underwent heart transplantation within the first month of BTT with an LVAD had significantly increased mortality. However, there was no survival difference among patients who were BTT with an LVAD longer than 31 days.
引用
- Brown CR, Khurshan F, Chen Z, et al. Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? J Thorac Cardiovasc Surg. 2019. PMID: 30955956. doi:10.1016/j.jtcvs.2018.12.118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。